FundraiseBase by

Bionyra Pharma

Raised $165M in a Series A round, announced 22 June 2026.

Round

Bionyra Pharma raised $165M in a Series A funding round.

Amount: $165M
Stage: Series A
Announced: 22 June 2026
Leads: Jeito Capital, Sofinnova Partners
Other investors: Arkin Bio, Sanofi Ventures, Sixty Degree Capital, Vives Partners, Apollo Health Ventures
Checked: Amount and date checked against the press source

Company

Develops next-generation biologics for immune-mediated inflammatory diseases, including atopic dermatitis and inflammatory bowel disease.

Based in: Paris and Boston
Sector: Other
Website: bionyra.com ↗

Founder

Frédéric MarracheCo-founder and CEO

Sources and links

Source: Bionyra Pharma Raises $165M in Series A Funding - FinSMEs news.google.com
Website: bionyra.com ↗

Just raised?

MediaBoost gets your round in front of the press, future hires and your next investors.

Announce your round with MediaBoost